Загрузка...
P-Glycoprotein Inhibition Sensitizes Human Breast Cancer Cells to Proteasome Inhibitors
Although effective for the treatment of hematological malignancies, the FDA approved proteasome inhibitors bortezomib and carfilzomib have limited efficacy in solid tumors including triple negative breast cancer (TNBC). Chemotherapy is the only option for treating TNBC due to the absence of specific...
Сохранить в:
| Опубликовано в: : | J Cell Biochem |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6858998/ https://ncbi.nlm.nih.gov/pubmed/27813130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcb.25783 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|